Vous avez cherché: unresponsive (Anglais - Maltais)

such patients are unresponsive to puregon/ hcg therapy.
dawn il- pazjenti ma jirrispondux għat- terapija ta ’ puregon/ hcg.

such patients are unresponsive to follitropin alfa/hcg therapy.
dawn il- pazjenti ma jirrispondux għat-terapija ta’ follitropin alfa/hcg.

such patients are unresponsive to gonal-f/hcg therapy.
dawn il- pazjenti ma jirrispondux għat-terapija ta’ gonal-f/hcg.

neuroleptic malignant syndrome, cerebral ischaemia, unresponsive to stimuli, loss of
koordinazzjoni mhux normalie, ras tirtogħode

patients may be unresponsive to the usual doses of adrenaline used to treat the allergic reactions.
il-pazjenti jistgħu ma jirrispondux għad-dożi normali ta’ adrenalina użati biex jiġu trattati reazzjonijiet allerġiċi.

became floppy, unresponsive or unconscious after the previous vaccination, within 48 hours of vaccination.
kienu mitluqa, ma kinux qed jirrispondu jew kienu mitlufin minn sensihom wara t-tilqima preċedenti, fi żmien 48 siegħa mit-tilqima.

anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate.
nuqqas ta’ ovulazzjoni (inkluż is-sindrome poliċistiku fl-ovarji) f’nisa li fuqhom il-kura bi clomifene citrate ma kinitx effettiva.

anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomifene citrate.
meta ma jkunx hemm ovulazzjoni (inkluż fil- mard polċistiku ta ’ l- ovarji (pocd) f’ nisa li ma rrispondewx għall- kura bi clomifene citrate.

blood vessel problems in the brain, coma due to uncontrolled diabetes, unresponsive to stimuli, low level of consciousness, shaking of the head
problemi fil-vażi tad-demm tal-moħħ, koma minħabba dijabete mhix ikkontrollata, nuqqas ta’ rispons għall-istimuli, livell baxx ta’ koxjenza, ras tiċċaqlaq

the use of botulinum toxin type-b in the treatment of patients who have become unresponsive to botulinum toxin type-a -- initial experiences.
the use of botulinum toxin type- b in the treatment of patients who have become unresponsive to botulinum toxin type- a -- initial experiences.

such patients are unresponsive to fertavid/ hcg therapy. • in men, semen analysis is recommended 4 to 6 months after the beginning of treatment in assessing the response.
dawn il- pazjenti ma jirrispondux għat- terapija ta ’ fertavid/ hcg. • fl- irġiel huwa rakkomandat, li ssir l- analiżi għal 4 sa 6 xhur wara l- bidu tal- kura biex jiġi eżaminat ir- rispons.

while taking beta-blockers, patients with a history of atopy or a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge with such allergens and unresponsive to the usual dose of adrenaline used to treat anaphylactic reactions.
waqt li kienu qed jieħdu imblokkaturi tar-riċetturi beta, pazjenti bi storja medika ta’ atopija jew titratta ta’ reazzjoni anafilattika severa għal varjetà ta’ allerġeni jistgħu jkunu iktar reattivi għal sfida ripetuta b’allerġeni bħal dawn u ma jirrispondux għad-doża normali tal-adrenalina li tintuża biex tikkura reazzjonijiet anafilattiċi.

puregon is indicated for the treatment of female infertility in the following clinical situations: • anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomifene citrate. • controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [e. g. in vitro fertilisation/ embryo transfer (ivf/ et), gamete intra- fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)].
puregon huwa intiż għall- kura ta ’ l- infertilità fin- nisa fis- sitwazzjonijiet kliniċi li ġejjin: • meta ma jkunx hemm ovulazzjoni (inkluż fil- mard polċistiku ta ’ l- ovarji (pocd) f’ nisa li ma rrispondewx għall- kura bi clomifene citrate. • stimulazzjoni eċċessiva kkontrollata ta ’ l- ovarji sabiex tistimula l- iżvilupp tal- follikuli multipli fi programmi mediċi ta ’ riproduzzjoni assistita [eż. fertilizzazzjoni/ trasferiment ta ’ l- embriju in vitro (ivf/ et), trasferiment tal- gamete intra- fallopjan (gift) u injezzjoni intraċitoplażmika ta ’ l- isperma (icsi)]